Skip to main content
Clinical Trials/ACTRN12619001374156
ACTRN12619001374156
Completed
未知

Development and evaluation of an Acceptance and Commitment Therapy (ACT) based lifestyle education intervention for patients with pre-diabetes: A randomised controlled trial

Massey University Psychology Department, Palmerston North0 sites87 target enrollmentOctober 9, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Massey University Psychology Department, Palmerston North
Enrollment
87
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 9, 2019
End Date
October 31, 2016
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Massey University Psychology Department, Palmerston North

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria required that patients were:
  • 1\. Over the age of 18
  • 2\. Fluent in spoken and written English
  • 3\. Had a formal classification of pre\-diabetes from a registered medical professional.
  • The prediabetes inclusion criteria were based on World Health Organisation (WHO) criteria for pre\-diabetes classification. This requires patients to have an impaired fasting glucose (IFG between 6\.1 and 6\.9 mmol\-1 inclusive) and an impaired glucose tolerance (IGT 2 hour postprandial glucose concentration between 7\.8 and 11 mmol), and/or an HbA1c between 41 and 49\.

Exclusion Criteria

  • 1\. Cognitively impaired.
  • 2\. At risk of harm to/from themselves or others (i.e., suicidal/homicidal ideation).
  • 3\. Comorbid medical diagnosis or condition that is terminal and likely to be fatal within one year.
  • 4\. Already participating in a formal pre\-diabetes lifestyle education intervention.
  • 5\. Receiving psychiatric or psychological intervention at the time of recruitment or has a severe psychiatric disorder (e.g., schizophrenia).
  • 6\. Meets criteria for type 2 diabetes. Again, this is based on WHO criteria (i.e., IFG greater than or equal to 7mmol/l, and/or 2\-hour plasma glucose of greater than or equal to 11\.1 mmol/l and/or HbA1c of 50 mmol/l or greater).

Outcomes

Primary Outcomes

Not specified

Similar Trials